Septerna, Inc. Files 8-K Report

Ticker: SEPN · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1984086

Sentiment: neutral

Topics: 8-K, filing, financials

TL;DR

Septerna filed an 8-K, likely with financial updates. Check for details.

AI Summary

On March 3, 2025, Septerna, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statements and Exhibits. No specific financial figures or material events beyond the filing itself were detailed in the provided text.

Why It Matters

This filing indicates Septerna, Inc. is providing updated information to the SEC, which could include financial statements or other material disclosures relevant to investors.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure (8-K) without immediate negative or positive news, making the immediate risk low.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Septerna, Inc.?

The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.

When was this 8-K report filed?

The report was filed on March 3, 2025.

What is Septerna, Inc.'s state of incorporation?

Septerna, Inc. is incorporated in Delaware.

What is Septerna, Inc.'s principal executive office address?

The principal executive offices are located at 250 East Grand Avenue, Suite 65, South San Francisco, CA 94080.

What is Septerna, Inc.'s SIC code?

Septerna, Inc.'s Standard Industrial Classification code is 2834, Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding Septerna, Inc. (SEPN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing